Decapitated dolphin in North Carolina prompts $25,000 reward offer from US
The 8-foot-long bottlenose dolphin was found dead on Lea-Hutaff Island, North Carolina, on April 15, according to a statement from the Office of Law Enforcement of the National Oceanic and Atmospheric Administration (NOAA).
The reward notice included a photo of the dolphin, which was missing its head, as it lay on the shore of the remote, undeveloped barrier island, which is north of Wilmington, North Carolina, and only accessible by boat, the agency said.
Officials from the University of North Carolina at Wilmington, which partners with NOAA to respond to dolphin strandings in the region, said that they determined that someone intentionally removed the dolphin's head after it had been stranded on the island.
The agency noted that the dolphin was carrying Brucella, a bacteria that causes the infectious disease brucellosis, which can be transferred to humans through direct contact. Symptoms of the disease include headaches, fever, sweating and generally feeling badly or malaise, according to the Centers for Disease Control and Prevention.
Officials performed a necropsy, an animal autopsy, and the results and cause of death were pending.
Dolphins are not listed as endangered or threatened under the Endangered Species Act, but they are protected under the Marine Mammal Protection Act, which bans harassing, hunting, killing or feeding wild dolphins. Violations can lead to fines up to US$100,000 and up to one year in jail.
Officials said that anyone with information about the Lea-Hutaff Island's dolphin should call the NOAA Enforcement Hotline at (800) 853-1964. People can leave tips anonymously, but to be eligible for the reward, they must include their name and contact information.
The agency has previously offered rewards to the public for information about dolphins that appeared to have been killed. In 2024, it offered up to a US$20,000 reward in exchange for information to find the person who they believe fatally shot a juvenile dolphin at a beach in Louisiana.
And in 2020, federal authorities offered a reward after two dead dolphins were found with gunshot or stab wounds in Florida. NYTIMES
Join ST's Telegram channel and get the latest breaking news delivered to you.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
a day ago
- Straits Times
With just 1 tap, this doctor lost his Telegram account to cyber criminals
In a poll by the Cyber Security Agency of Singapore, only 13 per cent of respondents were able to distinguish between all phishing and legitimate content In 2024, there were 8,552 cases of phishing scams in Singapore in 2024, placing it among the top five scam types. Minutes after Dr Chai Chwan tapped on a link within a Telegram message from an acquaintance, his phone buzzed non-stop. A flood of Telegram messages poured in from 10 friends, asking the 60-year-old general practitioner the same urgent question: 'Is your Telegram account hacked?' They had all received an identical Telegram message sent from Dr Chai's phone number. It contained a link inviting recipients to apply for We Care @ North East Fund, a genuine scheme by the North East CDC that provides financial support to needy families. The text claimed there was a 'limited time' offer for Singaporeans to receive up to $1,000 in cash assistance and urged recipients not to 'miss out'. That was when Dr Chai realised he had fallen prey to a phishing scam. His Telegram account was compromised. In phishing scams, victims are tricked into clicking malicious links or into revealing personal information. The scam happened on a Saturday afternoon in July this year. Just 10 minutes earlier, Dr Chai had received the same link from an acquaintance. Without thinking, he tapped on it. The page that opened mimicked a Singpass login. Dr Chai tapped the QR code, but an error message appeared. This glitch saved him from handing over his personal data, but it didn't stop scammers from hijacking his Telegram account. Within minutes, the same scam message was sent to Dr Chai's Telegram contacts, this time under his name. What followed was a scramble to report the incident to both the police and Telegram. Dr Chai also spent the next few hours sending warning messages in batches to all 7,000 of his phone contacts, hoping to contain the damage. He's unsure how many of his friends received the phishing text on Telegram. 'I feel quite embarrassed,' Dr Chai admits. 'It should have been common sense (not to click on the link).' With scams becoming more sophisticated, it can be hard to spot phishing attempts, says Mr Luke Ho, deputy director of National Cyber Threat Analysis Centre of the Cyber Security Agency of Singapore (CSA). In the CSA's Cybersecurity Awareness Survey 2024, only 13 per cent of respondents were able to distinguish between all phishing and legitimate content. The survey polled 1,050 respondents aged 15 years and above on their attitudes towards cyber incidents and their awareness and adoption of good cyber hygiene practices. Phishing scams 101 There were 8,552 cases of phishing scams in Singapore in 2024, placing it among the top five scam types, say the police. Victims lost at least $59.4 million. How it works: Scammers impersonate legitimate individuals or organisations on social media and messaging platforms. Upon clicking on links embedded within messages on these platforms, victims are directed to a fraudulent site. They will be asked to key in their personal, bank login or credit card details. Scammers then gain access to their messaging or bank accounts. They may even impersonate the victims to scam their circle of acquaintances, family members and friends. Evolving tactics Why is it becoming harder to spot phishing scams? One reason is the use of generative artificial intelligence by scammers, says Mr Ho. 'Scammers (can) now create content that is increasingly indistinguishable from legitimate ones.' Gone are the days when poor grammar or awkward phrasing gave phishing messages away, he adds. Cyber criminals also increasingly use security certificates – depicted as 'https' in the URL – in their fake websites. Mr Ho adds that scammers often exploit emotions, such as the fear of missing out, or the false sense of urgency in Dr Chai's situation. Such tactics pressure victims to respond quickly without checking the legitimacy of the messages. Taking action Staying safe from scams requires more than just awareness, says Mr Ho. It requires a change in how we behave online. He shares some actions that one can take to protect against scams: Set strong passwords and enable two-factor authentication – such as using biometric features, like fingerprint or facial recognition, for your online accounts Ensure that your devices are running the latest version of its software by enabling automatic updates Install the ScamShield app to filter out scam messages and block scam calls Install anti-virus apps to detect and remove malware, and malicious phishing links If you're unsure whether something is a scam, 'always check with official sources by calling the 24/7 ScamShield helpline at 1799,' Mr Ho says, 'or with family members and friends before proceeding.' For Dr Chai, the anxiety from the phishing scam has not fully gone away. 'There's always this discomfort,' he shares, from the fear that scammers still have personal information of his that they haven't used. And though his bank accounts remain secure, Dr Chai has since taken extra steps to protect himself. He downloaded the ScamShield app that helps to block out reported scam numbers and messages, giving him some peace of mind.
Business Times
3 days ago
- Business Times
The world needs more than drugs to fight obesity, writes Novo Nordisk's ex-boss
OVER the next decade, obesity and associated chronic diseases will have a profound impact on economies and global health. Yet for all the publicity around weight-loss treatments, it is clear that pharmaceuticals alone cannot solve a crisis that already affects over a billion people worldwide. The challenge lies not just in developing medicines and other interventions, but also in finding ways to prevent obesity and other chronic diseases before they start. As chief executive of Novo Nordisk from 2017 until earlier this month, I had a front-row seat to the promise and limitations of pharmaceutical interventions. These interventions have shown potential in weight management, but they cannot on their own address the economic and environmental factors that contributed to the obesity epidemic in the first place. The latest forecasts in the Lancet are stark: more than half of adults and one in three children and adolescents are set to be obese or overweight by 2050. This represents not just a health catastrophe but an economic one. The annual global cost of obesity alone is forecast to reach US$4.3 trillion by 2035. The economic burden posed by other chronic conditions linked to obesity, including diabetes and cardiovascular disease, will be measured in the trillions too. Such eye-popping numbers underline the futility of any notion that treatment alone can be a silver bullet. Radical rethink needed If we are to reverse a curve trending in the wrong direction since the 1990s, a radical rethink is needed. The next five years are crucial: In parts of the population, notably children and adolescents, the number of people living with obesity is set to overtake the number who are overweight but not obese. Shirking from the urgent policy intervention that's needed would be a monumental societal failing. A shift in focus is needed on many fronts. Obesity must be universally recognised and addressed as a multi-faceted societal responsibility rather than an individual one. This means restrictions on junk-food marketing to children and continued work to reduce the stigma associated with the disease. It also calls for urban planning that supports people's health, for instance by emphasising physical exercise over travelling by car. In short, the world must prioritise prevention. This may sound counterintuitive coming from a pharmaceutical executive. But the reality is that even if every person living with obesity took medicines, we couldn't treat our way out of this crisis. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Obesity science has come a long way. It is now widely accepted that socioeconomic, genetic and environmental factors play an important role in the development of the disease. Appetite regulation and the body's resistance to weight loss are also much better understood. We know it is not just a matter of calories in and calories out. Moreover, our improved understanding of the hormones regulating glucose levels and appetite reinforces the argument for a holistic approach to interconnected cardiometabolic diseases. The evidence is clear: Obesity is associated with numerous comorbidities. Cancer, type-2 diabetes, sleep apnoea, liver disease, chronic kidney disease, Alzheimer's and cardiovascular disease – the biggest cause of death globally – often overlap in people living with obesity. Earlier interventions to prevent obesity are not simply about limiting weight gain; they are about enabling good long-term health. This emerging area of science also offers clues as to how health care might be redesigned to be more patient-centred. The norm is for cardiologists to focus solely on cardiovascular disease while endocrine consultants treat patients with diabetes. A holistic approach built around the patient, rather than clinical specialisms, is the way forward. As data collection and analysis methods improve, so does the ability to gain new insights into why people develop obesity and which interventions work. This is an area in which the private sector can step up to help governments with limited resources, competing demands and a burning need to effect change now to invest in the most effective measures. Novo Nordisk is working with policymakers and academics as part of the Childhood Obesity Prevention Initiative: a controlled study across six cities in Brazil, Canada, France, Japan, South Africa and Spain, which is evaluating interventions to improve diets and boost physical activity among 6,000 children from disadvantaged communities. At the end of the programme, the plan is to produce a framework to guide regional and global policy decisions. More public-private action in this area must follow with pooled investment and, where appropriate, data-sharing. Obesity interventions of this kind could mark a milestone in human healthcare. However, if managing a single disease in isolation remains the sole legacy of this era of scientific progress, the world will have missed an opportunity to fundamentally change how society views and deals with chronic disease. Having recently stepped down after eight years at the top of Novo Nordisk, I am filled with hope rather than despair. Yes, the obesity epidemic is a huge challenge. But I have witnessed what is possible when science, policy and human determination align. I have seen patients improve their health and confidence. I have watched governments begin to act, from healthcare reforms to urban-planning reforms. Most importantly, I have observed a fundamental shift in the understanding of obesity: from an issue of individual responsibility to a condition requiring comprehensive and holistic care. The tools exist. The science is clear. Now we need to act on our knowledge. My generation may have created this crisis, but the next generation, armed with a deeper understanding and hopefully wiser policies, can solve it. ©2025 The Economist Newspaper Limited. All rights reserved The writer was chief executive of Novo Nordisk from January 2017 to August 2025
Business Times
3 days ago
- Business Times
Buffett buys US$1.6 billion UnitedHealth stake, sells T-Mobile
[NEW YORK] Warren Buffett's Berkshire Hathaway bought shares of UnitedHealth Group in the second quarter, sending the health insurer's stock soaring in post-market trading. The chief executive officer of the Omaha, Nebraska-based conglomerate acquired five million shares in UnitedHealth, granting Berkshire a stake worth US$1.6 billion, according to a filing on Thursday (Aug 14). Berkshire also sold its US$1 billion stake in T-Mobile US during the period, exiting the telecommunications operator. Buffett's investment in UnitedHealth comes as the health company faces multiple crises. Last year, a UnitedHealth executive, Brian Thompson, was shot to death in Manhattan. UnitedHealth, along with other US health insurers, has also faced unexpected increases in medical costs. In April, it reported earnings below Wall Street estimates for the first time in more than a decade, sending the stock price plummeting. It has since replaced its CEO and announced plans to replace its chief financial officer. The disclosure of Berkshire's UnitedHealth stake pushed the insurer's shares up as much as 9.6 per cent in post-market trading on Thursday. Apple, BOA trim Buffett also sold 20 million shares of Apple during the period, after slashing his holding in the iPhone manufacturer last year. Berkshire's Apple stake remains its largest equity stake by market value, despite it falling by about US$9.2 billion in the three months ended Jun 30. Berkshire also renewed its effort to trim its holding in Bank of America (BOA), selling 26 million shares and bringing its stake down to about 8 per cent at the end of June. Buffett started whittling down the bank investment last year, without providing any explanation for the move. One of its equity bets, a stake in consumer foods giant Kraft Heinz, has been a headache for Buffett's company. The conglomerate took a US$3.8 billion impairment charge on its investment earlier this year, and kept its holding unchanged in the second quarter. Meanwhile, Berkshire tweaked its investment in US homebuilders, building its stake in Lennar and selling shares of DR Horton. The company also bought more shares of steel manufacturer Nucor. Those changes were omitted in a previous filing as the company requested confidentiality treatment from the Securities and Exchange Commission. BLOOMBERG
